Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

For the latest in biomarkers & precision medicine, sign up for our monthly newsletter to be among the first to receive exclusive insights, in-depth market analyses, and expert articles directly to your inbox

A New Golden Age for Target Identification: Accessing the Novel Druggable Space with Discovery Proteomics

On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient
Watch Now

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Liquid Biopsies

Blood Biomarkers Signal Increased Risk of Alzheimer's & MND After Multiple Rugby Concussions

Results that show rugby players that have sustained multiple concussions present with markers of neurodegenerative disease development.
Read More
Personalised Medicine

Life Science Players Join €23m European Project for Precision Medicine, PRECISEU

The project will bring together life science institutions across European nations in the interest of expanding development of and access to advanced therapy medicinal products.
Read More
Biomarker Discovery & Development

A New Golden Age for Target Identification: Accessing the Novel Druggable Space with Discovery Proteomics

On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient
Read More
Liquid Biopsies

Feinstein Institutes Links Blood Biomarkers to Psychosis in Alzheimer's Patients

The global aging population means that rates of Alzheimer's disease are expected to reach 14 million patients by 2060, many of whom will experience psychosis.
Read More
Genomic Biomarkers

ZERO Precision Medicine Programme Reports Outstanding Efficacy in High-Risk Paediatric Cancers

The first-of-its-kind trial presents a positive outlook for cancer types with historically poor survival rates.
Read More
Genomic Biomarkers

Hope for New Prognostic Biomarkers & Therapeutic Options From Tumour Metabolism-Targeting Breast Cancer Study

Understanding the interplay between the tumour microenvironment and immunometabolic states could unlock a wealth of therapeutic targets and biomarkers.
Read More
Diagnostic Development

New Zika-Specific Synthetic Biomarker Can Differentiate From Dengue Virus

A test that identifies Zika distinct from dengue could make a definite impact to expectant mothers and reproductive-age women that are at risk from the mosquito-borne disease.
Read More
Diagnostic Development

Blood Test for Alzheimer's Granted Breakthrough Device Status by FDA

A blood test for the phosphorylated protein pTau-217 could be a critical step towards early diagnosis and screening of Alzheimer's disease.
Read More

New MND Early Diagnostic Test: a 'Game-Changer' for Research on the Disease

Detecting the aggregation of TDP-43 spells a new diagnostic tool for MND.
Read More
Biomarker Discovery & Development

The Power of Real-World Data Analytics in Biomarker Discovery: A Game-Changer in Medical Research

Biomarker discovery in medical research traditionally relied on controlled trials. Now, Real-World Data Analytics offers a transformative approach, analyzing real-world patient data to identify new biomarkers and improve patient care.
Read More
Digital Biomarkers

Speech-Analysis Tool for the Early Detection of Alzheimer's Handed to Linus Health in Acquisition

Aural Analysis's Speech Vitals and Linus Health's expansion into linguistic analysis herald a promising era in early detection and treatment.
Read More
Biomarker Discovery & Development

Abcam: Cancer Biomarkers Guide

Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things biomarkers